Stock Research: COSMOS Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

COSMOS Pharmaceutical

TYO:3349 JP3298400007
47
  • Value
    33
  • Growth
    55
  • Safety
    Safety
    60
  • Combined
    47
  • Sentiment
    50
  • 360° View
    360° View
    47
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

COSMOS Pharmaceutical Corporation operates drug stores, offering medical goods, cosmetics, and general food products. In the last fiscal year, the company had a market cap of $4962 millions, profits of $1481 millions, and revenue of $7022 millions.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
33 31 23 17
Growth
55 69 51 75
Safety
Safety
60 55 69 67
Sentiment
50 91 49 45
360° View
360° View
47 79 42 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
68 57 29 29
Opinions Change
11 62 39 50
Pro Holdings
n/a 83 67 49
Market Pulse
48 71 75 65
Sentiment
50 91 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
33 31 23 17
Growth
55 69 51 75
Safety Safety
60 55 69 67
Combined
47 50 37 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
48 48 43 38
Price vs. Earnings (P/E)
48 41 27 29
Price vs. Book (P/B)
42 43 39 36
Dividend Yield
35 25 18 14
Value
33 31 23 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
64 70 70 65
Profit Growth
73 69 26 21
Capital Growth
34 48 44 55
Stock Returns
27 29 67 71
Growth
55 69 51 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
73 75 82 86
Refinancing
6 11 24 24
Liquidity
80 79 90 90
Safety Safety
60 55 69 67

Similar Stocks

Discover high‑ranked alternatives to COSMOS Pharmaceutical and broaden your portfolio horizons.

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Brother Industries

TYO:6448
Country: Japan
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Shikoku Electric Power

TYO:9507
Country: Japan
Industry: Electric Utilities
Size: Large
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: